The first full session of the Clinical Pharmacology course, collaboratively organised and delivered by #Cambridgeuniversity and #AstraZeneca, was held and the following topics were covered: - Drug receptor interactions illustrated by G protein coupled receptors - ADME and pharmacokinetics in non- clinical species - Safety evaluation of organ-specific toxicity in First In Human Thank you to the speakers for the stimulating presentations. #Clinicalpharmacology
Claudio Marchese’s Post
More Relevant Posts
-
It was a pleasure to support this PSI ITIT session at our AstraZeneca site in Göteborg. A special thanks to Marianne Uguen, Ana Laura Stål, CAPM® , Mauritz Kööhler, Stéphanie Klein Tuente, PhD Ruth Lowe, Katarina Halling, Heleen van Haalen, Carl Mellström, Mario Ouwens, Folke Folkvaljon Tom Rouse, Martin Sidaway , Jacob Knagenhjelm I look forward to participating in the final session.
The fifth out of six sessions on Patient Reported Outcomes (PROs) and Reimbursement as part of the 2023/2024 ITIT course was held from Wednesday, May 29th to Thursday, May 30th. A big thank you to AstraZeneca in Gothenburg, Sweden, for hosting this session! We are grateful to all the speakers at AstraZeneca for their time and for delivering highly engaging and very informative presentations. The delegates received an insightful overview of Clinical Outcome Assessments (COAs), PROs, Health Economics, and Reimbursement. A special thank you to Claudio Marchese for his assistance in organizing the session. We are eagerly organizing and anticipating our final session on Medical and Market Access and looking ahead to planning for next year! To learn more about the ITIT course, please visit our website at https://lnkd.in/eKBgwu-x. Registration is open for the 2024/2025 course, with applications closing at midnight on June 21, 2024 🙌
-
-
Thank you to Amgen - see you in Göteborg for the next session where AstraZeneca will be hosting!
A massive thank you to Amgen in Cambridge for hosting a very successful 4th session on clinical trials as part of the 2023/2024 ITIT course. Thank you to everyone at Amgen who gave up their time to share their knowledge and thank you to Lucy DeCosta and Cathy Stokes for organising the session. The delegates got an overview of clinical trial planning, found out what clinical program operations, regulatory affairs, patient safety, and observational research really do as well as being treated to a workshop on estimands and discussions on some current hot topics in clinical trials. If you would like find out more about the ITIT course please visit our website https://lnkd.in/eKBgwu-x. Registration is open for the 2024/2025 course with applications closing at midnight on 21st June 2024 🙌
-
-
Excited to announce my recent certification in Pharmacometrics Spring School 2024: Modeling and Simulations with MonolixSuite™. Delving into PK, PD, modeling and clinical pharmacology has been enriching. Big thanks to my colleague Camille Riff for recommending this course! #Pharmacometrics #PKPD #ClinicalPharmacology MonolixSuite Simulations Plus, Inc. .
This content isn’t available here
Access this content and more in the LinkedIn app
-
I'd like to express my gratitude to #AstraZeneca for enabling my participation in the third session of the #PSI #ITIT Course 2023/2024, which emphasized #Data #Management activities and the essential role of #CROs in delivering innovative drugs to patients. Many thanks to #ICON for hosting us at their #Swansea site in Wales and sharing their knowledge. I look forward to the upcoming session.
-
-
I am grateful to #AstraZeneca for granting me the opportunity to join the second session of the #PSI #ITIT Course 2023/2024, focused on #toxicology in #preclinical studies. Huge thanks to #Janssen for hosting us at the #Beerse site and sharing their knowledge. Looking forward to the next session.
-
